Taken together, the protective effect of P. distasonis treatment on type 2 diabetes may be in part due to the production of these tryptophan metabolites, potentially leading to the increased differentiation and expression of barrier integrity cell-associated genes such as Claudin-1, Occludin, ZO-1, and MUC2. The gene discussed is CLDN1; the disease is type 2 diabetes mellitus.